Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray.
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
Type 1 diabetes and susceptibility to multiple sclerosis: What is the truth?
Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Extracranial Head and Neck Schwannomas: Our Experience.
MRI differential diagnosis of suspected multiple sclerosis.
Nerve conduction velocity in CMT1A: what else can we tell?
A combined exercise model for improving muscle strength, balance, walking distance, and motor agility in multiple sclerosis patients: A randomized clinical trial.
Beta interferon decision is 'disappointing'.
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratio.
Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient mice.
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study.
The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Risk factors in multiple sclerosis: a population-based case-control study in Sicily. Background and methods.
Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation.
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
Transverse Myelitis and Neuromyelitis Optica Spectrum Disorders.
Optimizing electrodiagnosis for Guillain-Barré syndrome: Clues from clinical practice.
Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan.
Acute transverse myelitis of the cervical spine secondary to psoas abscess.
Pages
« first
‹ previous
…
799
800
801
802
803
804
805
806
807
…
next ›
last »